Polymyxin B Sulfate and Trimethoprim (Falcon Pharmaceuticals, Ltd.)
Welcome to the PulseAid listing for the Polymyxin B Sulfate and Trimethoprim drug offered from Falcon Pharmaceuticals, Ltd.. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Falcon Pharmaceuticals, Ltd. |
NON-PROPRIETARY NAME: | Polymyxin B Sulfate and Trimethoprim |
SUBSTANCE NAME: | POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1998-04-16 |
END MARKETING DATE: | 0000-00-00 |
Polymyxin B Sulfate and Trimethoprim HUMAN PRESCRIPTION DRUG Details:
Item Description | Polymyxin B Sulfate and Trimethoprim from Falcon Pharmaceuticals, Ltd. |
LABELER NAME: | Falcon Pharmaceuticals, Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10000; 1([USP’U]/mL; mg/mL) |
START MARKETING DATE: | 1998-04-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61314-628_cb0ac4cf-047b-4c0e-9380-74913c1a6551 |
PRODUCT NDC: | 61314-628 |
APPLICATION NUMBER: | ANDA064211 |
Other POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE Pharmaceutical Manufacturers / Labelers: